Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-dose Prasugrel vs Clopidogrel in Elderly ACS Patients Undergoing Early PCI
NCT01777503Phase 4Completed
- Sponsor
- Azienda USL-IRCCS di Reggio Emilia
- Start
- Nov 2012
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of prasugrel in acute coronary syndrome (ACS), sponsored by Azienda USL-IRCCS di Reggio Emilia. Started Nov 2012; status: completed.
02
Drugs
prasugrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01777503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01777503.